SKACH05X0 (to W.R.S.). Mass spectrometric analysis was performed by the OHSU Proteomics Shared Resource with support from P30EYE010572, P30CA069533, S10OD012246, and S10RR025571. U.S. patent application 13/664,252 covers the methodology to assess and redesign the NBD1 coding sequences, claiming priority to provisional application 61/553,861, filed on 31 1 Stefano Volpi, 6, 7 Fabien G. Lafaille, 1 Céline Trouillet, 5 Mirco Schmolke, 4 Randy A. Albrecht, 4, 8 Elisabeth Israelsson, 9 Hye Kyung Lim, 1 Melina Casadio, 1 Tamar Hermesh, 1 Lazaro Lorenzo, 10, 11 Lawrence W. Leung, 4 Vincent Pedergnana, 10, 11 Bertrand Boisson, 1 Satoshi Okada, 1, 12 Capucine Picard, 1, 10, 11, 13 Benedicte Ringuier, 14 Françoise Troussier, 15 Damien Chaussabel, 9,16 † Laurent Abel, 1,10,11 † Isabelle Pellier, 17, 18 † Luigi D. Notarangelo, 6 † Adolfo García-Sastre, Severe influenza disease strikes otherwise healthy children and remains unexplained. We report compound heterozygous null mutations in IRF7, which encodes the transcription factor interferon regulatory factor 7, in an otherwise healthy child who suffered lifethreatening influenza during primary infection. In response to influenza virus, the patient's leukocytes and plasmacytoid dendritic cells produced very little type I and III interferons (IFNs). Moreover, the patient's dermal fibroblasts and induced pluripotent stem cell (iPSC)-derived pulmonary epithelial cells produced reduced amounts of type I IFN and displayed increased influenza virus replication. These findings suggest that IRF7-dependent amplification of type I and III IFNs is required for protection against primary infection by influenza virus in humans. They also show that severe influenza may result from singlegene inborn errors of immunity.
B
oth seasonal and pandemic influenza viruses typically cause self-limiting respiratory disease but occasionally cause life-threatening acute respiratory distress syndrome (ARDS). The frequency of severe disease depends on the viral strain (1). Known host risk factors to severe influenza consist of a few acquired comorbidities, such as chronic pulmonary disease (2, 3) . The pathogenesis of most cases of lifethreatening influenza remains unexplained, especially among children (4) . The lack of severe influenza in patients with known primary immunodeficiencies, including inborn errors of T and/or B cell immunity that predispose to a variety of related infections such as severe parainfluenza (5), is also unexplained (6). Only haploinsufficiency for GATA2, resulting in abnormal hematopoietic cell development, was reported in a few patients with severe influenza and other infections (7) . Monogenic inborn errors of immunity may underlie life-threatening, isolated diseases in otherwise healthy children during primary infection by a few other viruses (8) . We therefore hypothesized that severe influenza striking otherwise healthy children may also result from single-gene inborn errors of immunity.
We performed whole-exome sequencing (WES) in a 7-year-old girl ("P"), one of 22 individuals sequenced (including only three children <5 years old) proven to have developed influenza in the course of primary infection ( each parent being heterozygous for a single mutated allele (Fig. 1A and fig. S2B ), which defined the best candidate genotype in this patient (9) . Interferon regulatory factor 7 (IRF7) is a transcription factor that amplifies interferon (IFN) production in response to viruses (10) (11) (12) . Specifically, IRF7 is involved in the amplification of mouse and human type I (13 IFNA, IFNB, IFNE, IFNK, IFNW) and type III (IL29, IL28A, IL28B) IFN genes (11) (12) (13) . The missense F410V substitution is predicted to be damaging and absent in public databases. The nonsense Q421X (Fig. 1B  and fig. S2B ) is found as a heterozygous variant in 1 out of 118,062 chromosomes of the Exome Aggregation Consortium (ExAC) cohort, yielding a minor allele frequency of 0.000008. There are currently no homozygous or compound heterozygous nonsynonymous mutations found in our in-house (table S3) and public databases (ExAC). Thus, autosomal recessive IRF7 deficiency by compound heterozygosity may underlie severe influenza in this child.
Each mutation was loss-of-function in reporter assays driven by IFNB, IFNA4, or IFNA6 promoters ( Fig. 1C) (11) . None of the other five heterozygous IRF7 variants tested was loss-of-function (table  S4 and fig. S3 ). IRF7 can be activated by RIG-I recognition of IAV genomic RNA, resulting in C-terminal serine phosphorylation by the IKKrelated kinases TBK1 and IKK-e (11, (14) (15) (16) (17) (18) (19) (20) . Wildtype IRF7 was phosphorylated upon overexpression of TBK1, as was F410V (Fig. 1D) . The truncated Q421X product lacks the C-terminal serine residues and was not phosphorylated (Fig. 1D) . Phosphorylation induces IRF7 nuclear accumulation and transcription of type I and III IFNs (11, (14) (15) (16) . Wild-type IRF7 accumulated in the nuclei of all transfected Vero cells by 8 hours post-infection (hpi) with Sendai virus (SeV) ( Fig. 2A) , whereas F410V was cytoplasmic ( Fig. 2B ) and Q421X was nuclear with or without SeV infection (Fig. 2C ). This suggested that F410V disrupts a potential nuclear localization signal (amino acids 417 to 440) and was consistent with Q421X missing the nuclear export signal (amino acids 448 to 462) (15) .
The two mutant IRF7 alleles led to loss of function by different mechanisms: F410V did not accumulate in the nucleus despite phosphorylation, whereas Q421X resided in the nucleus without phosphorylation. The mutant IRF7 proteins could homo-or heterodimerize (Fig. 2D) , which suggests that coexpression might enable nuclear unphosphorylated Q421X to shuttle phosphorylated cytoplasmic F410V to the nucleus, where IRF7 mutant heterodimers could up-regulate IFNs. However, there was no nuclear relocalization of F410V or the wild type in the presence of Q421X SCIENCE sciencemag.org 24 ( Fig. 2E) . Consistently, there was no rescue in reporter assays when the two mutants were coexpressed ( fig. S4A ). Moreover, neither allele was dominant negative in terms of IRF7 or IRF3 function ( fig. S4, B to D) . This is consistent with the lack of infectious phenotype, including severe influenza, in P's heterozygous parents. Overall, the patient's severe influenza may result from lack of functional IRF7 homodimers, or IRF3-IRF7 heterodimers, or both. We investigated the genome-wide impact of IAV infection in peripheral blood mononuclear cells (PBMCs) by microarray, quantitative polymerase chain reaction (qPCR), and enzyme-linked immunosorbent assay (ELISA). At baseline, PBMCs from P displayed significant down-regulation of innate immune genes ( fig. S5 ). We observed a robust induction of type I IFN genes IFNA14, -16, -7, -2, -10, -13, and -21 (in order of relative change); IFNE; and IFNW1, as well as type III IFN genes IL29 and IL28A, in healthy donors but not in P, at 8 and 16 hpi (Fig. 3A) . Among IFN genes, the only exception was a factor of 2 induction of IFNB in P, albeit this was less than in controls by a factor of 4. Ingenuity pathway analysis software independently predicted IRF7 as an upstream regulator of these genes (P = 2.02 × 10 S6 ). IFN-b and IFN-l1 levels were impaired but less so than IFN-a, whereas IL-6 production was normal ( fig. S6, B to D) . Overall, we observed an overwhelming and selective defect of type I and III IFN induction in P's PBMCs.
In mice and humans, IRF7 is constitutively expressed in plasmacytoid dendritic cells (pDCs), resulting in pDCs being the major type I IFNproducing cells (25, 26) . We measured IFN-a2 production in response to pH1N1 infection in P's pDCs (Fig. 3C ), which were found at normal frequency (table S5) . We observed no IFN-a2 production in pDCs from P at 24 hpi with pH1N1 and herpes simplex virus-1 (HSV-1) (Fig. 3C) . MX1 induction was abolished, while that of IL8 was normal (Fig. 3D) . The patient's heterozygous mother produced IFN-a2 like controls ( fig. S7A) . We quantified the induction of all 20 human type I and type III IFN genes by qPCR in purified pDCs and unsorted PBMCs after infection with pH1N1 (Fig. 3, E and F) . At 8 hpi, P was deficient for type I IFN (including the 13 IFNA, IFNE, IFNK, and IFNW) and type III IFN (IL29, IL28A, and IL28B) genes in both cell preparations (Fig.  3, E and F, and fig. S7B ). IFNB was, however, mildly induced in P's pDCs (Fig. 3E) , and the induction of MX1 in P at 8 hpi was normal ( fig. S7C ). Collectively, a small amount of IRF7-independent IFN-b triggered early ISG up-regulation at 8 hpi in pDCs, but the IRF7-dependent amplification of type I and III IFNs was lacking for sustained ISG induction at 24 hpi.
We investigated the impact of IRF7 deficiency on cell-intrinsic, nonhematopoietic immunity, using P's SV40-immortalized fibroblasts (F-SV40). Basal and IFN-b-induced IRF7 mRNA expression in F-SV40 from P was normal (Fig. 4A ). In contrast, IRF7 protein expression was diminished, even after IFN-b treatment (Fig. 4B) . We observed approximately 2-log higher titers of IAV at 48 hpi relative to healthy controls (Fig. 4C) . Stable transfection of wild-type IRF7 complemented this phenotype (Fig. 4C) . Wild-type IRF7 similarly rescued enhanced replication of vesicular stomatitis virus (VSV) (Fig. 4C) . Highly pathogenic avian H5N1 IAV also replicated to high titers in P's F-SV40, indicating that the phenotype was not IAV strainspecific ( fig. S8A) . Further, treatment with exogenous IFN-a2b protected the fibroblasts from IAV and VSV replication ( fig. S8, B and C) . IFN-b production by fibroblasts was impaired after IAV infection (fig. S8D) ; however, it was normal after stimulation with extracellular or intracellular polyinosine-polycytidine (synthetic doublestranded RNA) ( fig. S8E ). This is consistent with intact IRF3-dependent signaling ( fig. S4D ) and detectable IFN-b production in P's PBMCs ( fig. S6A ).
IAVs first target the entire respiratory tract, with pH1N1 2009 viral antigen present in type I and type II pneumocytes in humans (2, 27) . We generated patient-specific pulmonary epithelial cells (PECs) from induced pluripotent stem cells (iPSCs) derived from P's primary fibroblasts (28) . IAV replication and IFN-b induction were compared in PECs derived from an embryonic stem cell line (RUES2), a SeV-reprogrammed healthy control iPSC line (SV-iPSC), and three independent IRF7-deficient iPSC clones. IRF7 expression in response to IFN-a, IFN-b, and IFN-l1 treatment and IFN-b production in response to IAV were impaired in P lines (Fig. 4, D and E) . Overall titers of IAV appeared equal regardless of IRF7 genotype, largely because of efficient replication in cells negative for Nkx2.1, a pulmonary epithelium marker in these cultures. However, when we scored the infected Nkx2.1 + cells for IAV nucleoprotein (NP) antigen (Fig. 4F) , 52.4% of P's PECs were double positive, versus 27.2% in controls (Fig. 4G) . This phenotype was rescued by treatment with IFN-a2b (Fig. 4G), IFN-b, or  IFN-l1 (fig. S9 ). These data suggest that impaired intrinsic immunity in the pulmonary epithelium may have contributed to P's ARDS. Impaired IFN production by P's pDCs may also have caused disease, as evidenced by the pulmonary cell rescue with exogenous IFN-a2b.
A single-gene inborn error of IRF7 immunity can underlie life-threatening, isolated influenza in humans during primary infection, broadening the range of human infections that result from genetic lesions (8, 9, 29, 30) . IRF7 deficiency disrupts the main function of pDCs, the production of antiviral IFNs. This is distinct from deficiencies of IRF8 and GATA2 that impair development of all circulating monocytes and DCs and of multiple myeloid and lymphoid subsets, respectively (7, 31, 32) . IRF7 deficiency also affects cell-autonomous, intrinsic immunity in PECs. The lack of IRF7-dependent type I and III IFN amplification by pDCs, PECs, or possibly other cell types likely underlies the patient's severe influenza. Interestingly, IRF7 is redundant for vaccine-mediated immunity to influenza viruses, as the child has been healthy for 5 years with annual influenza vaccination as the sole secondary prevention. The IRF7-deficient child, now 7 years old, also displays a narrow infectious phenotype, restricted to severe influenza, at odds with the broad role of mouse IRF7 in antiviral immunity (10, 30) . Human IRF7 seems to be largely redundant in host defense against viruses. It will be important to search for deficiencies in IRF7 and related genes in children with influenza and other severe viral illnesses. Our study provides proof of principle that single-gene inborn errors of immunity can cause severe childhood influenza. IFN-based, patient-tailored therapeutic strategies could be helpful in life-threatening influenza of childhood (33, 34) .
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C ells undergo regulated self-destruction during development and in response to stresses (1) . Axons, the longest cellular structures in the body, have a locally mediated selfdestruction program that removes damaged axons but also promotes axon loss in the setting of neurological disorders (2) . Axon degeneration is antagonized by the Wallerian degeneration slow (Wld s ) chimeric protein (3). The active moiety of Wld s is the enzyme nicotinamide mononucleotide adenyltransferase 1 (Nmnat1), which synthesizes the essential cofactor nicotinamide adenine dinucleotide (NAD + ) (4), but the function of Nmnat1 and NAD + in axon protection remains unclear (2) . The protein SARM1 (sterile alpha and TIR motif-containing 1; TIR, Toll-interleukin receptor) is an essential mediator of axon degeneration (5, 6) . SARM1 is a negative regulator of Toll-like receptor-activated transcriptional programs (7), but its mechanism for axon degeneration is unknown.
To investigate whether SARM1 functions before or after injury, we engineered a system to inactivate SARM1 with pharmacologic control. Protease-sensitized SARM1 (SARM ps ) contains a tobacco etch virus (TEV) protease consensus sequence between the sterile alpha motif (SAM) and TIR domains, which are both essential for SARM1 function (6) . SARM ps is thus cleaved and inactivated by TEV protease. SARM ps was fused to the rapamycin-binding domain Frb and the N-terminal portion of split TEV protease (Ntev) (8) and coexpressed with C-terminal split TEV fused to FK866 binding protein (Fkbp-Ctev), allowing rapamycin-induced cleavage (Fig. 1A and  fig. S1 ). In dorsal root ganglion (DRG) neurons, cleavage of SARM ps was mostly complete within 60 min of rapamycin treatment (Fig. 1B and  fig. S2A ). SARM ps functionality was verified by expression of SARM ps in isolated Sarm1 −/− DRG neurons. When Sarm1 −/− axons were severed (diagrammed in Fig. 1C ), they remained intact after 24 hours, whereas axons of neurons expressing SARM ps showed degeneration measured by axon morphometry (Fig. 1D) , similar to wild-type axons. SARM ps function was lost upon cleavage triggered by rapamycin in the presence of Fkbp-Ctev (Fig. 1, D and E) or by expression of full-length TEV ( fig. S2B ). Cleavage of SARM ps initiated 12 hours before or up to 2 hours after axon transection fully suppressed axon degeneration measured 24 hours after axotomy. Because cleavage of SARM ps after axons were disconnected from cell bodies resulted in protection, SARM1 must function after injury to promote degeneration. SARM1 has no predicted enzymatic function but contains a TIR domain, which is the effector domain of Toll-like receptors (TLRs). Activation of TLRs results in dimerization of TIR domains that transmit a signal to cytosolic effector proteins (9) . We tested whether multimerization of the TIR domain of SARM1 (sTIR) might induce axon degeneration. A minimal region of human SARM1 comprising sTIR and the adjacent multimerization (SAM) domains, but lacking the autoinhibitory N terminus (SAM-TIR), is constitutively active and promotes cell and axon destruction in cultured DRG neurons (6) . Expression of this activated form of SARM1 in vivo in Drosophila motor ( Fig. 2A) or sensory neurons (fig. S3 ) also caused cell and axon destruction. This degeneration was not observed in Drosophila expressing SAM-TIR harboring a disruptive sTIR mutation.
To evaluate the sufficiency of sTIR dimerization in axon destruction, we engineered a pharmacologically controlled dimerizable sTIR by fusing it to the rapamycin-binding domains Frb and Fkbp (Fig. 2B) (10) . We expressed Frb-sTIR and Fkbp-sTIR in DRG neurons and found that sTIR dimerization by rapamycin induced axon fragmentation within 12 hours (Fig. 2C) and neuronal cell death within 24 hours (Fig. 2D) . sTIRinduced toxicity did not require the inhibition of mammalian target of rapamycin (mTOR), because the rapamycin analog AP20187, which does not target mTOR, also stimulated axon degeneration in cells expressing the homodimerizable Fkbp F36V -sTIR (10) . SARM1 activation is thus sufficient to elicit axonal and neuronal destruction. Cell and axon degeneration were not induced upon dimerization of the TIR domains of TLR4 or the adaptor MYD88 (Fig. 2E) .
We tested whether SARM1 promotes axon degeneration through a local mechanism. sTIRinduced degeneration does not require a physical connection between the axon and soma: Sarm1 −/− axons persisted after severing; however, sTIR dimerization by AP20187 caused fragmentation of these severed segments within 12 hours (Fig.  2F) . Dimerization of sTIR locally within axons also led to selective axon destruction. We grew DRG neurons in adjacent fluid compartments: one containing the cell bodies and proximal axons and the other containing only distal axons (Fig.  2G) . Application of AP20187 to both compartments led to destruction of proximal and distal axons, whereas selective application to the distal
